Indeed, following stable GABPB1 knockdown, glioblastoma cells carrying C228T or C250T TERT promoters undergo diminished TERT/telomerase expression, progressive telomere erosion and eventual loss of tumorigenic potential (55). The gene discussed is TERT; the disease is glioblastoma.